Leon E. Rosenberg
Presidente en Talon Therapeutics, Inc. .
Cargos activos de Leon E. Rosenberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Presidente | 01/02/2004 | - |
Independent Dir/Board Member | 01/02/2004 | - | |
Princeton University | Corporate Officer/Principal | 01/09/1997 | - |
Yale University | Corporate Officer/Principal | 27/04/2011 | - |
Historial de carrera de Leon E. Rosenberg
Antiguos cargos conocidos de Leon E. Rosenberg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Email Real Estate.com, Inc. | Director/Miembro de la Junta | - | 13/10/2004 |
BRISTOL-MYERS SQUIBB COMPANY | Director Técnico/Científico/I+D | 01/01/1997 | 01/03/1998 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Presidente | 01/09/1991 | 01/01/1997 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Director/Miembro de la Junta | 01/01/2000 | - |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Director/Miembro de la Junta | 01/01/1997 | - |
KARO PHARMA AB (PUBL) | Presidente | - | - |
Formación de Leon E. Rosenberg.
University of Wisconsin | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Suecia | 2 |
Suiza | 2 |
Operativa
Director/Board Member | 3 |
Chairman | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Consumer Services | 4 |
Health Technology | 4 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
KARO PHARMA AB (PUBL) | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Empresas privadas | 5 |
---|---|
Email Real Estate.com, Inc. | Finance |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Commercial Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute |
- Bolsa de valores
- Insiders
- Leon E. Rosenberg
- Experiencia